Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • chicken
    Junior Member
    • Sep 2016
    • 3

    #1

    only short fragments (90, 124bp) after amplification

    Dear community,

    I am new at RNA seq with Illumina and hope you can help me.
    We use the MiSeq System with the TruSeq Stranded mRNA Sample Prep Kit. I do low throughput.
    After the amplification step I do a BioAnalyzer analysis to check the sample before pooling.
    The BioAnalyzer shows me 2 peaks, one at approximately 90bp and one at 124bp. Any suggestions what this could be? I think its adapter dimers but I really dont know how they occur? Does anyone had that problem previously??
    Dont hesitate to ask further questions.
  • cmbetts
    Senior Member
    • Jun 2012
    • 120

    #2
    124 is almost certainly adapter dimers. I'm unfamiliar with the Illumina kit, but there's usually a step that involves diluting the adapter to be the appropriate concentration for the amount of insert present.
    Also, how much RNA are you starting with? You might be having issues either from starting from too little material or with your mRNA enrichment method.

    Comment

    • microgirl123
      Senior Member
      • Jun 2012
      • 199

      #3
      Do you have a peak for your library also or just unligated adapter/adapter dimer peaks?

      Comment

      • chicken
        Junior Member
        • Sep 2016
        • 3

        #4
        Hey thanks for your suggestions. Now I am quite sure that the peaks show adapter dimers. Unfortunately my kit manual does not show the option to dilute the adapter. Is this not common in illumina kits? I am starting with 500ng of total RNA. Any suggestions about diluting Adapter??

        Comment

        • pmiguel
          Senior Member
          • Aug 2008
          • 2328

          #5
          The TruSeq kits do not include a protocol for titrating adapter concentrations. If you end up with only adapter dimers it just means that library construction failed. Contact [email protected] for help.

          --
          Phillip

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            Yesterday, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 02:55 AM
          0 responses
          9 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Working...